Tallink Grupp
15.10.2026 08:00:00 CEST | Globenewswire | Press release
AS Tallink Grupp Investor Webinar introducing the third quarter 2026 results
AS Tallink Grupp Investor Webinar introducing the third quarter 2026 results
AS Tallink Grupp will present its third quarter 2026 financial results in an investor webinar. All shareholders and other interested parties are invited to participate in the webinar, which will take place on 22 October 2026 at 12:00 (EEST). The webinar will be held in English.
The financial results will be presented by Peep Jalakas, Chairman of the Management Board.
Participants are kindly asked to submit their questions in advance by email to investor@tallink.ee, no later than 11:00 (EEST) on 22 October 2026. Due to time constraints, priority will be given to questions submitted in writing before the webinar.
How to join the webinar?
The webinar will be hosted on the Microsoft Teams platform. No prior registration is required, and no reminder will be sent. We recommend that all interested parties add the event to their calendars. To participate, please join the webinar on 22 October 2026 at 12:00 (EEST) using the following link.
Participants can join via a web browser or the Microsoft Teams application. When joining from a mobile device, participants may need to download the Microsoft Teams application from Google Play or the App Store.
The webinar will be recorded and made available on the Company's website under Reports & Financial key figures following the event.
Anneli Simm
Investor Relations Manager
AS Tallink Grupp
Sadama 5
10111 Tallinn, Estonia
E-mail anneli.simm@tallink.ee
Phone: +372 5615 7170
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VyOS Networks15.10.2026 08:00:00 CEST | Press release
VyOS Announces Partnership with ADESTIS to Support Sovereign Cloud and Multi-Cloud Networking
OMass Therapeutics15.10.2026 08:00:00 CEST | Press release
OMass Therapeutics Announces $310 Million Series C Financing to Advance Portfolio of Small Molecule Therapeutics in Endocrinology and Immunology
Kuros Biosciences AG15.10.2026 07:00:00 CEST | Press release
Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
Alkane Resources Limited15.10.2026 02:58:31 CEST | Press release
Deep Drilling Intersects Epithermal Mineralisation 1 km Below Proprietary Pit at Peak Hill
Chongqing Changan Automobile Co., Ltd.14.10.2026 21:51:43 CEST | Press release
Firmly Rooted, Growing Together: Changan Automobile Continues to Strengthen Localised Operations in Europe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom